시장보고서

상품코드

1631183

전자 약물전달 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product (Auto Injectors), By Application (Cardiovascular Disease), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

발행일: 2024년 12월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전자 약물전달 시스템 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 전자 약물전달 시스템 시장 규모는 2025-2030년까지 연평균 9.2%의 CAGR을 기록하며 2030년까지 201억 9,000만 달러에 달할 것으로 예상됩니다.

대량 및 고점도 생물학적 제제에 도움이 되는 주입 펌프와 자동 주사기를 중심으로 간편한 자가 투여 기술을 가능하게 하는 기술의 발전은 기업들에게 잠재적인 시장 기회를 창출하고 있습니다. 주입 펌프에 사용되는 새로운 제제의 승인은 새로운 치료 옵션을 제공함으로써 성인 당뇨병 치료를 진전시키고 있습니다.

2019년 10월, 노보 노디스크는 미국 식품의약국(FDA)으로부터 제1형 및 제2형 당뇨병 환자를 위한 인슐린 펌프용 인슐린 주사제 '피아스프(Fiasp)'에 대한 승인을 받았습니다. 또한, 혁신적인 웨어러블 수액 펌프를 통해 환자는 스마트폰 앱에 무선으로 연결할 수 있습니다. 이를 통해 의료 전문가는 환자의 데이터를 추적하고 개별 요구 사항에 따라 특정 치료를 조정할 수 있습니다. 앞서 언급 한 요인으로 인해 전자 약물전달 시스템에 대한 수요가 전 세계적으로 증가하고 있습니다. 그러나 자동 펌프는 기술적 결함으로 인한 오투약의 위험과 약물 부작용을 초래할 수 있습니다. 이는 시장 성장에 걸림돌이 될 수 있습니다.

전자 약물전달 시스템 시장 보고서 하이라이트

웨어러블 주입 펌프는 2024년 41.4%의 가장 큰 점유율을 차지했습니다. 당뇨병과 같은 만성질환을 관리하기 위한 최소침습적이고 사용자 친화적인 장치에 대한 수요 증가는 전자 약물전달 시스템 시장에서 웨어러블 주입 펌프의 주요 촉진요인으로 작용하고 있습니다.
당뇨병 부문은 2024년 36.4%의 가장 큰 시장 점유율을 차지했으며, 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
소매 약국 부문은 2024년 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다. 디지털 약국 서비스 및 주문 처리 네트워크의 발전으로 인해 처방약의 편리한 택배 배송에 대한 수요가 증가함에 따라 이 부문의 주요 촉진요인이 되고 있습니다.
북미 전자 약물전달 시스템 시장은 2024년 44.7%의 가장 큰 점유율을 차지했습니다. 이는 자동 주사기에 대한 정밀하고 신뢰할 수 있는 ISO 준수 검사 솔루션에 대한 수요가 증가하여 약물전달 기기의 최적의 성능과 안전성을 보장하기 때문입니다.

지역별 시장 점유율 분석, 2024년과 2030년
지역별 시장 대시보드
시장 규모와 예측 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

참여자 개요
기업의 시장 포지션 분석
기업 분류
전략 매핑
기업 개요/상장 기업
- Bayer AG
- Gerresheimer AG
- Medtronic
- Elcam Medical
- Novo Nordisk A/S
- Insulet Corporation
- Unilife Corporation(Amgen Inc.)
- BD

ksm 25.03.07

Electronic Drug Delivery Systems Market Growth & Trends:

The global electronic drug delivery systems market size is expected to reach USD 20.19 billion by 2030, registering a CAGR of 9.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Technological advancements allowing easy self-administration technologies, mainly in infusion pumps and auto injectors that help in large-volume and high-viscosity biologic drugs have created a potential market opportunity for the companies. Approvals of novel drug formulations for use in infusion pumps allow a novel treatment option, thereby advancing diabetes care in adults.

In October 2019, Novo Nordisk received the U.S. Food and Drug Administration approval for Fiasp, insulin injection for use in insulin pumps for patients with type 1 and 2 diabetes. Moreover, the innovative wearable infusion pumps allow the patients to wirelessly connect to smartphone apps. This enables healthcare professionals to track patient data and tailor specific therapies as per individual requirements. The aforementioned factors have augmented the demand for electronic drug delivery systems globally. However, automated pumps may have risks of wrong dosage with technical glitches and might lead to adverse drug reactions. This may hinder the market growth.

Electronic Drug Delivery Systems Market Report Highlights:

Wearable infusion pumps accounted for the largest share of 41.4% in 2024. The growing demand for minimally invasive, user-friendly devices for managing chronic conditions such as diabetes is a key driving factor for wearable infusion pumps in the electronic drug delivery systems market.
The diabetes segment held the largest market share of 36.4% in 2024 and is expected to grow at the fastest CAGR over the forecast period.
The retail pharmacies segment dominated the market with the largest revenue share in 2024. The growing demand for convenient home delivery of prescription medications, driven by advancements in digital pharmacy services and fulfillment networks, is a key driving factor for the segment.
North America electronic drug delivery systems market held the largest share of 44.7% in 2024, which can be attributed to the increasing demand for precise, reliable, and ISO-compliant testing solutions for autoinjectors, ensuring optimal performance and safety in drug delivery devices.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Electronic Drug Delivery Systems Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Electronic Drug Delivery Systems Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Wearable Infusion Pumps
- 4.4.1. Wearable infusion pumps market, 2018 - 2030 (USD Million)
4.5. Auto Injectors
- 4.5.1. Auto injectors devices market, 2018 - 2030 (USD Million)
4.6. Injection Pens
- 4.6.1. Injection pens market, 2018 - 2030 (USD Million)
4.7. Inhalers
- 4.7.1. Inhalers market, 2018 - 2030 (USD Million)

Chapter 5. Electronic Drug Delivery Systems Market: Application Business Analysis

5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Diabetes
- 5.4.1. Diabetes market, 2018 - 2030 (USD Million)
5.5. Cardiovascular Disease
- 5.5.1. Cardiovascular disease market, 2018 - 2030 (USD Million)
5.6. Respiratory disorders
- 5.6.1. Respiratory disorders market, 2018 - 2030 (USD Million)
5.7. Multiple sclerosis
- 5.7.1. Multiple sclerosis market, 2018 - 2030 (USD Million)
5.8. Others
- 5.8.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Electronic Drug Delivery Systems Market: Distribution Channel Business Analysis

6.1. Distribution Channel Market Share, 2024 & 2030
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
6.4. Hospital Pharmacies
- 6.4.1. Hospital pharmacies market, 2018 - 2030 (USD Million)
6.5. Retail Pharmacies
- 6.5.1. Retail pharmacies market, 2018 - 2030 (USD Million)
6.6. Online Pharmacies
- 6.6.1. Online pharmacies market, 2018 - 2030 (USD Million)

Chapter 7. Electronic Drug Delivery Systems Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework
  - 7.4.2.3. Competitive insights
  - 7.4.2.4. U.S. electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework
  - 7.4.3.3. Competitive insights
  - 7.4.3.4. Canada electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework
  - 7.4.4.3. Competitive insights
  - 7.4.4.4. Mexico electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework
  - 7.5.2.3. Competitive insights
  - 7.5.2.4. UK electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework
  - 7.5.3.3. Competitive insights
  - 7.5.3.4. Germany electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework
  - 7.5.4.3. Competitive insights
  - 7.5.4.4. France electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework
  - 7.5.5.3. Competitive insights
  - 7.5.5.4. Italy electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework
  - 7.5.6.3. Competitive insights
  - 7.5.6.4. Spain electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Denmark
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Regulatory framework
  - 7.5.7.3. Competitive insights
  - 7.5.7.4. Denmark electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Regulatory framework
  - 7.5.8.3. Competitive insights
  - 7.5.8.4. Sweden electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Norway
  - 7.5.9.1. Key country dynamics
  - 7.5.9.2. Regulatory framework
  - 7.5.9.3. Competitive insights
  - 7.5.9.4. Norway electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework
  - 7.6.2.3. Competitive insights
  - 7.6.2.4. Japan electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework
  - 7.6.3.3. Competitive insights
  - 7.6.3.4. China electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework
  - 7.6.4.3. Competitive insights
  - 7.6.4.4. India electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework
  - 7.6.5.3. Competitive insights
  - 7.6.5.4. Australia electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.6. South Korea
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework
  - 7.6.6.3. Competitive insights
  - 7.6.6.4. South Korea electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Regulatory framework
  - 7.6.7.3. Competitive insights
  - 7.6.7.4. Thailand electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework
  - 7.7.2.3. Competitive insights
  - 7.7.2.4. Brazil electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework
  - 7.7.3.3. Competitive insights
  - 7.7.3.4. Argentina electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
- 7.8.1. MEA electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework
  - 7.8.2.3. Competitive insights
  - 7.8.2.4. South Africa electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Regulatory framework
  - 7.8.3.3. Competitive insights
  - 7.8.3.4. Saudi Arabia electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Regulatory framework
  - 7.8.4.3. Competitive insights
  - 7.8.4.4. UAE electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key country dynamics
  - 7.8.5.2. Regulatory framework
  - 7.8.5.3. Competitive insights
  - 7.8.5.4. Kuwait electronic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Bayer AG
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial performance
  - 8.5.1.3. Product benchmarking
  - 8.5.1.4. Strategic initiatives
- 8.5.2. Gerresheimer AG
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial performance
  - 8.5.2.3. Product benchmarking
  - 8.5.2.4. Strategic initiatives
- 8.5.3. Medtronic
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial performance
  - 8.5.3.3. Product benchmarking
  - 8.5.3.4. Strategic initiatives
- 8.5.4. Elcam Medical
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial performance
  - 8.5.4.3. Product benchmarking
  - 8.5.4.4. Strategic initiatives
- 8.5.5. Novo Nordisk A/S
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial performance
  - 8.5.5.3. Product benchmarking
  - 8.5.5.4. Strategic initiatives
- 8.5.6. Insulet Corporation
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial performance
  - 8.5.6.3. Product benchmarking
  - 8.5.6.4. Strategic initiatives
- 8.5.7. Unilife Corporation (Amgen Inc.)
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial performance
  - 8.5.7.3. Product benchmarking
  - 8.5.7.4. Strategic initiatives
- 8.5.8. BD
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial performance
  - 8.5.8.3. Product benchmarking
  - 8.5.8.4. Strategic initiatives

전자 약물전달 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product (Auto Injectors), By Application (Cardiovascular Disease), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

전자 약물전달 시스템 시장 성장과 동향

전자 약물전달 시스템 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 전자 약물전달 시스템 시장 변수, 동향, 범위

제4장 전자 약물전달 시스템 시장 : 제품 비즈니스 분석

제5장 전자 약물전달 시스템 시장 : 용도 비즈니스 분석

제6장 전자 약물전달 시스템 시장 : 유통 채널 비즈니스 분석

제7장 전자 약물전달 시스템 시장 : 지역별, 추정·동향 분석